BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36343048)

  • 1. White coat hypertension is another clinical characteristic of patients with inflammatory bowel disease: A cross-sectional study.
    Premužić V; Prijić R; Jelaković M; Krznarić Ž; Čuković-Čavka S; Jelaković B
    Medicine (Baltimore); 2022 Nov; 101(44):e29722. PubMed ID: 36343048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
    Johansson MAK; Östgren CJ; Engvall J; Swahn E; Wijkman M; Nystrom FH
    J Hypertens; 2021 Oct; 39(10):2009-2014. PubMed ID: 33973957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial stiffness in children and adolescents with masked and sustained hypertension.
    Kollios K; Nika T; Kotsis V; Chrysaidou K; Antza C; Stabouli S
    J Hum Hypertens; 2021 Jan; 35(1):85-93. PubMed ID: 32099080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central pressures and central hemodynamic values in white coat hypertensives are closer to those of normotensives than to those of controlled hypertensives for similar age, gender, and 24-h and nocturnal blood pressures.
    Almeida J; Monteiro J; Silva JA; Bertoquini S; Polónia J
    Rev Port Cardiol; 2016 Nov; 35(11):559-567. PubMed ID: 27717519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis.
    Antza C; Vazakidis P; Doundoulakis I; Bouras E; Haidich AB; Stabouli S; Kotsis V
    J Clin Hypertens (Greenwich); 2020 May; 22(5):802-811. PubMed ID: 32356941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections.
    Sung SH; Cheng HM; Wang KL; Yu WC; Chuang SY; Ting CT; Lakatta EG; Yin FC; Chou P; Chen CH
    Hypertension; 2013 Jun; 61(6):1346-53. PubMed ID: 23608649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
    Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
    Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
    Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D
    Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial Stiffness in Treated Hypertensive Patients With White-Coat Hypertension.
    Barochiner J; Aparicio LS; Alfie J; Morales MS; Cuffaro PE; Rada MA; Marin MJ; Galarza CR; Waisman GD
    J Clin Hypertens (Greenwich); 2017 Jan; 19(1):6-10. PubMed ID: 27677467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White-coat hypertension/effect is associated with higher arterial stiffness and stroke events.
    Saunders A; Nuredini GN; Kirkham FA; Drazich E; Bunting E; Rankin P; Ali K; Okorie M; Rajkumar C
    J Hypertens; 2022 Apr; 40(4):758-764. PubMed ID: 35001033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nighttime mean arterial pressure is associated with left ventricular hypertrophy in white-coat hypertension.
    Yang X; Yuan Y; Gou Q; Ye R; Li X; Li J; Ma J; Li Y; Chen X
    J Clin Hypertens (Greenwich); 2022 Aug; 24(8):1035-1043. PubMed ID: 35791888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use.
    Paiva AMG; Gomes MICM; Campana ÉMG; Feitosa ADM; Sposito AC; Mota-Gomes MA; Nadruz W; Brandão AA
    Hypertens Res; 2019 Dec; 42(12):1989-1995. PubMed ID: 31506647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis.
    Hadizadeh S; Shahmohamadi E; Khezerlouy-Aghdam N; Heidary L; Tarafdari A; Hantoushzadeh S; Ayati A; Foroutani L; Ahmadi-Tafti H; Mohseni-Badalabadi R; Vahidi H; Hadizadeh A; Mousavi S
    Arch Gynecol Obstet; 2024 Mar; 309(3):929-937. PubMed ID: 37792010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensives.
    Ribeiro L; Gama G; Santos A; Asmar R; Martins L; Polónia J
    Blood Press Monit; 2000 Feb; 5(1):11-7. PubMed ID: 10804446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
    Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
    Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
    Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cardiovascular Risk of White-Coat Hypertension.
    Franklin SS; Thijs L; Asayama K; Li Y; Hansen TW; Boggia J; Jacobs L; Zhang Z; Kikuya M; Björklund-Bodegård K; Ohkubo T; Yang WY; Jeppesen J; Dolan E; Kuznetsova T; Stolarz-Skrzypek K; Tikhonoff V; Malyutina S; Casiglia E; Nikitin Y; Lind L; Sandoya E; Kawecka-Jaszcz K; Filipovský J; Imai Y; Wang JG; O'Brien E; Staessen JA;
    J Am Coll Cardiol; 2016 Nov; 68(19):2033-2043. PubMed ID: 27810041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
    Mancia G; Facchetti R; Grassi G; Bombelli M
    Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.
    Abolbashari M
    Curr Cardiol Rep; 2018 Mar; 20(4):25. PubMed ID: 29520630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.